Advisory Services Network, LLC Axsome Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$57.42 - $83.61 $44,213 - $64,379	770 New	770 $61,000
Q1 2023 May 17, 2023	SELL	$58.39 - $75.0 $4,379 - $5,625	-75 Reduced 5.33%	1,333 $82,000
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $56,235 - $112,245	1,408 New	1,408 $108,000
Q3 2021 Nov 05, 2021	SELL	$19.91 - $68.26 $14,434 - $49,488	-725 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$50.63 - $73.5 $36,706 - $53,287	725 New	725 $49,000
Q1 2021 May 24, 2021	SELL	$55.91 - $81.44 $40,534 - $59,044	-725 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$66.31 - $86.52 $23,208 - $30,282	350 Added 93.33%	725 $59,000
Q3 2020 Nov 16, 2020	BUY	$68.34 - $85.84 $25,627 - $32,190	375 New	375 $27,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.